PSMB9 and Hashimoto thyroiditis: In addition to demonstrating at the molecular and tissue levels that LMP2 is a marker of oncocytes (Hürthle cells) in Hashimoto thyroiditis, this study also reports that LMP2 is increased in thyroid cancer.